SCHEMBL6946852

SCHEMBL6946852

CC(C)C[C@@H](C(=O)NN(c1ccccc1)S(C)(=O)=O)[C@H](CC=Cc1nccs1)C(=O)NOC1CCCCO1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.40
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CCNA1 P78396 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP7 P09237 1/20 0.32
TGFBR1 P36897 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
P2RX3 P56373 1/20 0.30
POLB P06746 1/20 0.30
HCRTR2 O43614 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947352 0.89 ADAM17 (0.51) ADAM17CCNA2CDK2CCNA1CDK5
SCHEMBL6943306 0.86 ADAM17 (0.45) ADAM17MMP2MMP3MMP7TGFBR1
SCHEMBL6946107 0.85 ADAM17 (0.38) ADAM17MMP2MMP3MMP7P2RX3
SCHEMBL6945960 0.85 ADAM17 (0.51) ADAM17MMP2TGFBR1CA1CA2
SCHEMBL6942385 0.85 ADAM17 (0.45) ADAM17TGFBR1P2RX3POLB
SCHEMBL6942441 0.84 ADAM17 (0.45) ADAM17TGFBR1P2RX3
SCHEMBL6940024 0.84 ADAM17 (0.48) ADAM17MMP2MMP3POLB
SCHEMBL6946888 0.83 ADAM17 (0.48) ADAM17CCNA2CDK2CCNA1CDK5
SCHEMBL6944673 0.83 ADAM17 (0.46) ADAM17P2RX3
SCHEMBL6943881 0.83 ADAM17 (0.57) ADAM17MMP2MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed